OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2

PRESS RELEASE OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate...

By: GlobeNewswire

Oct 03 2024
32
10127 Views

OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2

PRESS RELEASE
OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2
Oxford, United Kingdom 1 October 2024 OMa… [+6199 chars]

Majority of Children With Spinal Muscular Atrophy (SMA) Treated With Genentech's Evrysdi Are Able to Sit, Stand and Walk Independently, Two-Year Data Demonstrate

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

For Girls to Succeed in STEM, Confidence Matters as Much as Competence

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical

Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Average Price Target from Analysts

United Nations summit gives Indigenous groups voice on nature conservation decisions

Agreement signed at UN summit gives Indigenous groups voice

Can viruses cause cancer?

Exploring the hemp market: legal cannabinoids for relaxation and relief

Life in the Ruins

6 Expert-Recommended Vitamins and Minerals That Unlock Healthy Aging

The Third Atomic Bomb: Self-replicating RNA vaccines

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2

Related